Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jan 9, 2007

Organon Extends Research Interest in China

  • Huya Bioscience will support Organon in the sourcing and development Chinese pharmaceutical or biopharmaceutical compounds in three specific therapeutic areas. As part of this collaboration, Organon has acquired an equity interest in Huya.

    David Nicholson, executive vp R&D at Organon points out that this collaboration agreement “is consistent with our research strategy to forge closer links with China's highly skilled and motivated scientists and significantly expands our own ongoing biotech research programs and capabilities.”

    This transaction follows other research collaborations that Organon has signed with Chinese biotech companies, such as Shanghai Genomics and HD Biosciences.



Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »